13 - 24 of 7277 results
0.58 CME CREDIT

Preventing HPV-Related Cancers in Our Communities: Expert Q&A

0.50 CME/MOC
0.58 AANP | 0.15 Pharmacology |

Human papillomavirus (HPV) is the most common sexually transmitted infection. In addition to causing cervical cancers, HPV is responsible for 90% of anal cancers and 70% of oropharyngeal cancers, and affects both men and women. This activity provides an update on the prevention of HPV-related cancers and the newly expanded vaccine indications.


0.25 CME CREDIT

COVID-19 is a novel virus that had profoundly affected the global population in a very sudden way. Although COVID-19 shares some similarities with other respiratory viruses such as influenza, it has important differences from other viruses with respect to its effects on pregnancy. This FAQ with OB/GYN Georges Sylvestre, MD covers many concerns that patients have when dealing with the COVID-19 pandemic while pregnant and will help understand the implications if COVID-19 if acquired during pregnancy. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 04/15/2020 and they are subject to change as new information is published.


Cardiovascular Risk in T2DM

1.50 CME/MOC
1.48 AANP | 1.13 Pharmacology |


0.32 CME CREDIT

Clinicians’ lack of obesity management knowledge may foil optimal treatment. This activity incorporates a “Man-on-the-Street” video to increase clinician awareness of patient perspectives on obesity management. Evidence-based and expert recommendations on talking with patients about obesity and means to address obstacles in long-term management, will be presented.


0.5 CME CREDIT

Clinicians’ lack of obesity management knowledge may foil optimal treatment. This activity incorporates a “Man-on-the-Street” video to increase clinician awareness of patient perspectives on obesity. Evidence-based and expert recommendations on talking with patients about obesity, therapeutic options—including pharmacotherapy—and means to address obstacles in long-term management will be presented.


0.5 CME CREDIT

Migraine treatment has a new and more powerful focus due to recently approved therapies that target migraine’s underlying pathophysiologic pathways. This online activity includes a discussion between a PCP and headache specialist about clinical best practices in the treatment of migraine and safety/efficacy of acute and preventive therapies.


0.6 CME CREDIT

This activity will provide an evidence-based approach to diagnosing irritable bowel syndrome (IBS) with minimal testing. Diagnostic tests that facilitate a positive diagnosis of IBS and effective approaches for educating patients will be highlighted. The panel will spotlight diet changes and over-the-counter agents which are helpful first-line therapies. Evidence-based guidelines will identify the most effective and best tolerated prescription agents for IBS and chronic constipation patients.